A review article on the the effect of Psoriasis on the U.S economy was published online by JAMA Dermatology. The authors reviewed factors that have a direct, indirect, intangible and comorbidity (presence of one or more additional disorders) costs of adult psoriasis and estimate that the annual U.S. cost of psoriasis for 2013 to be between $112 billion and $135 billion.
Psoriasis is a chronic inflammatory skin disease. It causes the skin to be irritable and form thick, red skin with flaky, silver-white patches called scales. These scales are dead skin cells that form on the surface.
The disease occurs when the immune system mistakes healthy skin cells as a threat and attacks it. It sends out a signal to speed up the growth of new skin cells. Dead skin cells builds up on the skin surface which become scales.
By releasing an estimated annual cost of the Psoriasis, researchers believe it will help develop cost effective therapies that will help alleviate this economic burden and improve patient outcome.
Psoriasis is a chronic inflammatory skin disease. It causes the skin to be irritable and form thick, red skin with flaky, silver-white patches called scales. These scales are dead skin cells that form on the surface.
The disease occurs when the immune system mistakes healthy skin cells as a threat and attacks it. It sends out a signal to speed up the growth of new skin cells. Dead skin cells builds up on the skin surface which become scales.
By releasing an estimated annual cost of the Psoriasis, researchers believe it will help develop cost effective therapies that will help alleviate this economic burden and improve patient outcome.